| 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 7Y | 10Y | Since launch | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fund | +11.35% | +4.42% | +12.33% | +21.31% | +18.01% | +19.94% | +15.73% | — | — | +15.56% |
| NIFTY Pharma TRI | +10.85% | +7.49% | +14.67% | +25.66% | +25.86% | +22.31% | +16.87% | — | — | — |
| Category middle | +7.16% | +0.76% | +8.62% | +4.78% | +4.45% | +14.50% | +13.44% | +17.71% | +15.62% | — |
| Volatility | 15.90% |
| Sharpe | 0.85 |
| Sortino | 1.34 |
| Beta | 0.98 |
| Alpha | -1.53% |
| Deepest fall | -17.69% |
| 1-year periods with a loss | 22% |
| 5Y SIP XIRR | — |
The fund house's monthly portfolio filing is not loaded.
Calculated by Growth Analyser from AMFI NAVs. Up to 1 year: total return; longer: CAGR. Research and education only; not investment advice. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance does not indicate future returns.